SQZ Biotechnologies Company(SQZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SQZ SQZ Biotechnologies Company

Delisted 07-03 13:00:00 EDT

0.4350

+0.0000

0.00%

High0.4350	Low0.4350	Vol0.00
Open0.4350	D1 Closing0.4350	Amplitude0.00%
Mkt Cap12.83M	Tradable Cap9.35M	Total Shares29.49M
T/O14.14M	T/O Rate0.00%	Tradable Shares21.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SQZ","market":"US","secType":"STK","nameCN":"SQZ Biotechnologies Company","latestPrice":0.435,"timestamp":1688403600000,"preClose":0.435,"halted":4,"volume":0,"delay":0,"floatShares":21485496,"shares":29491125,"eps":-2.611132,"marketStatus":"Delisted","change":0,"latestTime":"07-03 13:00:00 EDT","open":0.435,"high":0.435,"low":0.435,"amount":14140073.924966,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.611132,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1604030400000,"exchange":"NYSE","adjPreClose":0.435,"volumeRatio":0},"requestUrl":"/m/hq/s/SQZ/wiki","defaultTab":"wiki","newsList":[{"id":"2343188708","title":"BRIEF-SQZ Biotechnologies Receives NYSE Notification On Non-Compliance With NYSE Listed Company Manual","url":"https://stock-news.laohu8.com/highlight/detail?id=2343188708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2343188708?lang=en_us&edition=fundamental","pubTime":"2023-06-16 05:14","pubTimestamp":1686863697,"startTime":"0","endTime":"0","summary":"June 15 (Reuters) - SQZ Biotechnologies Co   :   * SQZ BIOTECHNOLOGIES CO -  ON JUNE 12, RECEIVED NYSE NOTIFICATION THAT COMPANY IS NOT IN COMPLIANCE WITH SECTION 802.01B OF NYSE LISTED COMPANY MANUALFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","SQZ","BK4139","NYSE","78472W203"],"gpt_icon":0},{"id":"2334794792","title":"SQZ Biotechnologies Q1 EPS $(0.60) Misses $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2334794792","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2334794792?lang=en_us&edition=fundamental","pubTime":"2023-05-11 05:06","pubTimestamp":1683752763,"startTime":"0","endTime":"0","summary":"SQZ Biotechnologies (NYSE:SQZ) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.51) by 17.65 percent. This is a 20 percent increase over losses of $(0.75) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/23/05/32329028/sqz-biotechnologies-q1-eps-0-60-misses-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQZ"],"gpt_icon":0},{"id":"2321791970","title":"Stocks to Watch: Coinbase, Agile Therapeutics, Steelcase, SQZ Biotechnologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2321791970","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2321791970?lang=en_us&edition=fundamental","pubTime":"2023-03-23 07:01","pubTimestamp":1679526060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TERN","SQZ","CRCT","BK4585","BK4588","BK4139","BK4143","BK4535","BK4551","BK4112","BK4584","COIN","SCS","BOLT","BK4539","BK4007","BK4191","LU1861558580.USD","AGRX","LU1861559042.SGD","BK4554"],"gpt_icon":0},{"id":"2321137769","title":"SQZ Biotechnologies Shares Advance 44% on Continued AAC Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2321137769","media":"marketwatch","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2321137769?lang=en_us&edition=fundamental","pubTime":"2023-03-23 05:12","pubTimestamp":1679519520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://images.barrons.com/im-749171?size=1.777777777777778&width=220 220w","type":0,"news_type":0,"thumbnails":["https://images.barrons.com/im-749171?size=1.777777777777778&width=220 220w"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.marketwatch.com/story/sqz-biotechnologies-shares-advance-44-on-continued-aac-trial-7e2ec775?mod=newsviewer_click","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mwatch_stock","symbols":["AAC","BK4535","SQZ","BK4561","BK4139"],"gpt_icon":0},{"id":"2321612913","title":"BRIEF-Sqz Biotechnologies Announces Confirmed Complete Response In Hpv16+ Solid Tumor Patient In The Lowest-Dose Cohort Of The Sqz-Aac-Hpv-101 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2321612913","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2321612913?lang=en_us&edition=fundamental","pubTime":"2023-03-23 04:51","pubTimestamp":1679518271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","SQZ","BK4139"],"gpt_icon":0},{"id":"2321182159","title":"SQZ Biotechnologies FY22 EPS $(2.76), Sales $21.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2321182159","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2321182159?lang=en_us&edition=fundamental","pubTime":"2023-03-23 04:46","pubTimestamp":1679517974,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/23/03/31465147/sqz-biotechnologies-fy22-eps-2-76-sales-21-5m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQZ"],"gpt_icon":0},{"id":"2304265217","title":"BRIEF-Sqz Biotechnologies Receives Notice Regarding Continued Listing Standards From The New York Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2304265217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2304265217?lang=en_us&edition=fundamental","pubTime":"2023-01-19 05:33","pubTimestamp":1674077629,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQZ","BK4139","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.SQZbiotech.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.","exchange":"NYSE","name":"SQZ Biotechnologies Company","nameEN":"SQZ Biotechnologies Company"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SQZ Biotechnologies Company(SQZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SQZ Biotechnologies Company(SQZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SQZ Biotechnologies Company,SQZ,SQZ Biotechnologies Company股票,SQZ Biotechnologies Company股票老虎,SQZ Biotechnologies Company股票老虎国际,SQZ Biotechnologies Company行情,SQZ Biotechnologies Company股票行情,SQZ Biotechnologies Company股价,SQZ Biotechnologies Company股市,SQZ Biotechnologies Company股票价格,SQZ Biotechnologies Company股票交易,SQZ Biotechnologies Company股票购买,SQZ Biotechnologies Company股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SQZ Biotechnologies Company(SQZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SQZ Biotechnologies Company(SQZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction